Landiolol manufacturers

Filters

landiolol

Powder for solution for infusion 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bosnia And Herzegovina , Greece
Manufacturer #17347
It was established in the 2000s. Over the years it has become one of the major players in Europe. The commitment to work and obligation towards patients inspires the company to deliver peak performance every day. They want to help – doctors in their work and patients in their recovery. Top-quality, prompt availability, and rapid solutions – especially in critical situations – are particularly important to the company.

landiolol

Vials, lyophilized injection 280 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years. The main therapeutic areas include CNS, ophthalmology, and dermatology. Main dosage forms include sterile and solid oral dosage forms. The company's production lines are cGMP-compliant. The company possesses branches in Europe, North America, and Asia.

landiolol

Injection 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
MHRA
Manufacturer #21871

Established in 2005, this manufacturer is a notable CTD dossier owner and manufacturer specializing in injectable medicinal products. Operating globally, it adheres to stringent GMP manufacturer standards, distributing its high-quality products in numerous countries. This CTD dossier owner and manufacturer utilizes cutting-edge production facilities, ensuring compliance and excellence as a GMP manufacturer and CTD dossier owner and manufacturer, further solidifying its position in the pharmaceutical industry.

 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.